<DOC>
	<DOC>NCT01498939</DOC>
	<brief_summary>This trial is conducted in Asia. The aim of this trial is to investigate the pharmacokinetics after a single dose of insulin detemir in healthy Chinese male subjects.</brief_summary>
	<brief_title>Pharmacokinetics of Insulin Detemir in Healthy Chinese Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<criteria>Body mass index (BMI) between 18 and 25 kg/m^2 (both inclusive) Fasting plasma glucose maximum 6 mmol/L Nonsmoker Considered generally healthy upon completion of medical history, physical examination and laboratory assessments, as judged by the Investigator Known or suspected allergy to trial product(s) or related products Previous participation in this trial. Participation is defined as randomisation Receipt of any investigational drug within the last three months prior to this trial History of alcohol or drug abuse</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>